MacleodWN. Sporadic non-A, non-B hepatitis and Epstein-Barr hepatitis associated with the Guillain-Barré syndrome. Arch Neurol1987; 44: 438–442.
3.
BocciaFFlorioLLDurante-MangoniE,et al.Guillain-Barré syndrome as clinical presentation of a recently acquired hepatitis C. J Neurovirol2023; 29: 640–643.
4.
ChlilekARogerCMullerL, et al.Severe Guillain-Barré syndrome associated with chronic active hepatitis C and mixed cryoglobulinemia: A case report. BMC Infect Dis2019; 19: 636.
5.
LacailleFZylberbergHHagègeH, et al.Hepatitis C associated with Guillain-Barré syndrome. Liver1998; 18: 49–51.
6.
MenonDJagtapSANairMD. Guillain-Barré syndrome following acute viral hepatitis A. J Neurosci Rural Pract2014; 5: 204–205.
7.
BaeYJKimKMKimKK, et al.A case of acute hepatitis A complicated by Guillain-Barré syndrome. Korean J Hepatol2007; 13: 228–233.
8.
FokkeCvan den BergBDrenthenJ, et al.Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain J Neurol2014; 137: 33–43.
9.
OnoSChidaKTakasuT. Guillain-Barré syndrome following fulminant viral hepatitis A. Intern Med Tokyo Jpn1994; 33: 799–801.
10.
XieJGCaiYDavisLE. Guillain-Barré syndrome and hepatitis A: Lack of association during a major epidemic. Ann Neurol1988; 24: 697–698.
11.
BalwaniMBawankuleCRamtekeV,et al.Hepatitis C virus, directly acting antivirals and Guillain-Barré syndrome. Saudi J Kidney Dis Transpl2018; 29: 1237–1239.
